Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Knowing when a retirement plan outperforms a 401k can significantly influence your retirement strategy. Find out the critical factors to consider.
27,035 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
A suspicious phone call claiming a court order pulled a Maryland woman into a tense sting. The scam fell apart throug...
AXT Inc. is poised for a pivotal earnings night after a dramatic rally. Look for updates on demand for indium phosphi...
The IMF says the U.S. economy remains robust, but mounting deficits and tariff policy threaten long-term balance. Thi...
Axel Springer has agreed to acquire Telegraph Media Group for £575 million ($766 million), ending a years-long sale s...
As tensions rise, Iran warns of $200 barrels even as the U.S. and IEA launch a massive emergency oil release. The mov...
When tech giants join forces, investors take notice. This article breaks down the huge news nebius stock and why Meta...
Two Dividend Kings confront mounting cash-flow pressures and strategic shifts as 2026 approaches. This story examines...
As the Senate Banking Committee prepares a pivotal vote, crypto stakeholders weigh the potential for regulatory clari...
Traders are increasingly turning to covered calls to generate income in a volatile market. One widely cited case clai...
A former lineman took a leap during the pandemic and built a $50 million knife company from a backyard workshop. The ...
Movement pivots from a speculative token project to a Layer 1 blockchain, backed by Circle and other partners, as it ...